BioCentury
ARTICLE | Finance

In latest Italy deal, Sofinnova seeds nanodelivery start-up NanoPhoria with €3.5M

Targeted, non-viral drug delivery start-up is eighth deal for European firm’s Italy-focused Telethon Fund

May 13, 2022 6:36 PM UTC

In the eighth disclosed deal for Sofinnova’s Italy-focused Telethon Fund, the firm has backed non-viral drug delivery start-up NanoPhoria as it advances an initial program for heart failure.

European firm Sofinnova Partners said it supplied €3.5 million ($3.6 million) in seed funding to Milan-based NanoPhoria s.r.l., a spinout from Italy’s Consiglio Nazionale delle Ricerche. The firm invested from its Sofinnova Telethon Fund, a €108 million ($117.4 million) vehicle set up to back genetic medicine start-ups in Italy...